Rare Disease Field Sales Leader - PI/CIDP (Boston/Virtual)

Takeda Pharmaceutical Company Limited; Boston (MA); Remote; USD 91,000 - 124,000; Full time

Job summary

Takeda Pharmaceutical Company Limited in Boston, MA is seeking a Rare Disease Business Manager for Primary Immunodeficiency and CIDP to lead regional sales efforts with healthcare professionals across Allergy/Immunology, Pulmonology, Infectious Disease and Neurology. You will drive patient starts, educate on Takeda therapies, and partner with specialty teams.

Join a matrix organization focused on compliant, patient-centered outcomes, data-driven strategy, and cross-functional collaboration to

Qualifications

• Bachelor's degree - BS/BA.
• 3+ years of successful selling experience in pharma/biotech or related field; OR 2+ years at Takeda.
• Excellent verbal and written communication.
• Ability to navigate complex selling environments and influence decision makers.
• Strong business acumen and strategic account management.

Responsibilities

• Achieve sales quotas by driving new patient starts, outpatient infusion centers and hospitals.
• Engage healthcare professionals with product information and educational resources.
• Understand office influence points across diagnosis, treatment, and Rx/referral processes.
• Participate in community education events for healthcare professionals and patients.
• Collaborate with Marketing, Patient Services, Integrated Health Systems and Market Access teams.

Skills

Territory planning

Account management

Data analysis

Verbal & written communication

Cross-functional collaboration

Education

BS/BA

Job description

Takeda Pharmaceutical Company Limited in Boston, MA is seeking a Rare Disease Business Manager for Primary Immunodeficiency and CIDP to lead regional sales efforts with healthcare professionals across Allergy/Immunology, Pulmonology, Infectious Disease and Neurology. You will drive patient starts, educate on Takeda therapies, and partner with specialty teams.

Join a matrix organization focused on compliant, patient-centered outcomes, data-driven strategy, and cross-functional collaboration to